Hemoglobin Decrease with Iron Deficiency Induced by Daclatasvir plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b

BACKGROUND: Decreased hemoglobin (Hb) level has been supposed to be a relatively rare side effect of a combination therapy against hepatitis C virus that consists of the NS5A inhibitor daclatasvir (DCV) and the NS3/4A protease inhibitor asunaprevir (ASV). METHODS: The study was conducted in 75 patie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Matsumoto, Nobuyuki, Ikeda, Hiroki, Shigefuku, Ryuta, Hattori, Nobuhiro, Watanabe, Tsunamasa, Matsunaga, Kotaro, Hiraishi, Tetsuya, Tamura, Tomohiro, Noguchi, Yohei, Fukuda, Yasunobu, Ishii, Toshiya, Okuse, Chiaki, Sato, Akira, Suzuki, Michihiro, Itoh, Fumio
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4798293/
https://ncbi.nlm.nih.gov/pubmed/26990758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0151238
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados